ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,267.84
-0.74%
US Tech 100
18,152.00
-0.42%
Dow Jones
39,065.26
-1.53%
Brent Oil
81.135
-0.22%
Bitcoin
67,659.60
-0.39%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. Biocartis Group NV (BCART)

  7. Biocartis Group NV (BCART) News

BCART

Biocartis Group NV (BCART)

Biocartis Group NV
Date:
Sort by:
 Showing the most relevant articles for your search:EU:BCART
DateTimeSourceHeadlineSymbolCompany
05/09/20241:00AMGlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meetingEU:BCARTBiocartis Group NV
01/10/20245:00PMGlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings)EU:BCARTBiocartis Group NV
01/10/20245:00PMGlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of large shareholdings)EU:BCARTBiocartis Group NV
11/22/20234:00AMGlobeNewswire Inc.Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansionEU:BCARTBiocartis Group NV
11/13/20231:00AMGlobeNewswire Inc.Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual MeetingEU:BCARTBiocartis Group NV
10/31/202310:55AMGlobeNewswire Inc.Press release Biocartis Group NV: Announcement regarding Enforcement by Secured CreditorsEU:BCARTBiocartis Group NV
10/20/20231:00AMGlobeNewswire Inc.Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO)EU:BCARTBiocartis Group NV
10/16/20231:00AMGlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer PortfolioEU:BCARTBiocartis Group NV
10/12/20231:00AMGlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations KitEU:BCARTBiocartis Group NV
10/03/20231:00AMGlobeNewswire Inc.Press Release Biocartis Group NV: Disclosure of transparency notificationEU:BCARTBiocartis Group NV
09/26/20231:00AMGlobeNewswire Inc.Press Release Biocartis Group NV: Agreement regarding recapitalization of operating subsidiaries by secured by secured creditors and wind down of listed holding companyEU:BCARTBiocartis Group NV
09/26/20231:00AMGlobeNewswire Inc.Press Release Biocartis Group NV: Biocartis announces H1 2023 Results and provides an update on the operational reorganization and recapitalizationEU:BCARTBiocartis Group NV
09/21/20231:00AMGlobeNewswire Inc.Press release Biocartis Group NV: Biocartis 2023 half-year results webcast on 26 September 2023EU:BCARTBiocartis Group NV
08/28/20231:00AMGlobeNewswire Inc.Press Release Biocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leadersEU:BCARTBiocartis Group NV
08/24/20231:00AMGlobeNewswire Inc.Press Release Biocartis Group NV: Biocartis Announces 2023 Half-Year Results on 26 September 2023EU:BCARTBiocartis Group NV
08/10/20231:00AMGlobeNewswire Inc.Press Release Biocartis Group NV: Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ PlatformEU:BCARTBiocartis Group NV
07/18/20231:00AMGlobeNewswire Inc.Press release Biocartis Group NV: Biocartis appoints George Cardoza as new CFO and Head of Service DeliveryEU:BCARTBiocartis Group NV
06/30/20231:00AMGlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of Outstanding Voting SecuritiesEU:BCARTBiocartis Group NV
06/20/202311:40AMGlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of transparency notificationEU:BCARTBiocartis Group NV
06/15/202311:15AMGlobeNewswire Inc.Press release Biocartis Group NV: Biocartis announces planned operational reorganization and cost reduction programEU:BCARTBiocartis Group NV
06/08/20231:00AMGlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of transparency notificationEU:BCARTBiocartis Group NV
06/05/202311:40AMGlobeNewswire Inc.Press release Biocartis Group NV: Biocartis announces resignation CFOEU:BCARTBiocartis Group NV
05/12/202311:40AMGlobeNewswire Inc.Press release Biocartis Group NV: Results of the Annual Shareholders’ Meeting held on 12 May 2023EU:BCARTBiocartis Group NV
05/09/20231:00AMGlobeNewswire Inc.Press release Biocartis Group NV: Biocartis and HiloProbe to Collaborate on Colorectal Cancer TestEU:BCARTBiocartis Group NV
04/28/202311:40AMGlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of Outstanding Voting SecuritiesEU:BCARTBiocartis Group NV
04/20/20231:00AMGlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2023EU:BCARTBiocartis Group NV
04/11/20234:00PMGlobeNewswire Inc.Press release Biocartis Group NV: Biocartis appoints Roger Moody as new CEOEU:BCARTBiocartis Group NV
04/11/20231:01AMGlobeNewswire Inc.Press release Biocartis Group NV: Invitation to the Annual Shareholders’ MeetingEU:BCARTBiocartis Group NV
04/11/20231:00AMGlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Announces Publication of 2022 Annual ReportEU:BCARTBiocartis Group NV
04/04/20231:00AMGlobeNewswire Inc.Press release Biocartis Group NV: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla™ platformEU:BCARTBiocartis Group NV
 Showing the most relevant articles for your search:EU:BCART

Your Recent History

BIT
P1JO96
BNP Paribas Issuance BV
BIT
P1D9V5
BNP Paribas Issuance
BIT
P1CSR3
BNP Paribas Issuance
BIT
P118Z2
Bnp Paribas Issuance
BIT
P1EM02
BNP Paribas Issuance
BIT
F12521
Vontobel Financial Produ...
BOV
RSUL3
RIO SULENSE ON
BIT
P10W71
Bnp Paribas Issuance
BIT
I06066
Banca Imi
BIT
PB3396
BNP PARIBAS ISSUANCE
BIT
SFL
Safilo
BIT
Z53508
Credit Suisse
BIT
P128B2
BNP PARIBAS ISSUANCE
BIT
Q00521
Leonteq Securities
BOV
BTAG11
Btg Pactual Credito Agri...
BIT
P1BWB1
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved